New hope in fight against rare, deadly eye cancer
Disease control
Completed
This study tested a new drug called IMCgp100 for people with advanced uveal melanoma, a rare and aggressive cancer that starts in the eye. It compared the new drug to standard treatment options to see which helped patients live longer. The trial involved 378 adults who had not ye…
Phase: PHASE2 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC